Literature DB >> 14657535

Chronic pain following treatment for cancer: the role of opioids.

Jane C Ballantyne1.   

Abstract

Opioids are the most effective analgesics for severe pain and the mainstay of acute and terminal cancer pain treatments. In those settings, opioids are used over a limited time period so that opioid tolerance, if it develops, is relatively easy to overcome, and other problems of opioid use, including substance abuse, are unlikely to be problematic. As cancer treatments improve and increasing numbers of cancer patients experience long remissions, chronic pain due to cancer, or to cancer treatment, becomes a clinical problem that oncologists will encounter. Chronic pain differs from acute and terminal pain in several fundamental respects. In the case of chronic pain, functional restoration is a predominant goal of treatment. Because it is often due to neuronal damage, the pain may be particularly sensitive to nonopioid medications, and opioids can be reserved for refractory pain. If opioids are chosen, tolerance, dependence, and addiction can interfere, and safeguards designed to minimize these must be built into the treatment plan. This article reviews the principles of chronic opioid therapy for non-cancer pain and how these principles may be adapted for patients with chronic pain due to cancer.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14657535     DOI: 10.1634/theoncologist.8-6-567

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


  13 in total

1.  Gaps and junctions between clinical experience and theoretical framework in the use of opioids.

Authors:  Marianne Kloke
Journal:  Support Care Cancer       Date:  2004-11       Impact factor: 3.603

2.  Substance use disorder and its effects on outcomes in men with advanced-stage prostate cancer.

Authors:  Sumedha Chhatre; David S Metzger; S Bruce Malkowicz; George Woody; Ravishankar Jayadevappa
Journal:  Cancer       Date:  2014-07-09       Impact factor: 6.860

3.  Long-Term Opioid Therapy in Older Cancer Survivors: A Retrospective Cohort Study.

Authors:  Rahul Shah; Lin-Na Chou; Yong-Fang Kuo; Mukaila A Raji
Journal:  J Am Geriatr Soc       Date:  2019-04-26       Impact factor: 5.562

4.  Opioid use determines success of videothoracoscopic splanchnicectomy in chronic pancreatic pain patients.

Authors:  Tomasz Stefaniak; Ad Vingerhoets; Wojciech Makarewicz; Lukasz Kaska; Jarek Kobiela; Barbara Kwiecińska; Aleksander Stanek; Andrzej J Lachinski; Zbigniew Sledziński
Journal:  Langenbecks Arch Surg       Date:  2007-04-14       Impact factor: 3.445

Review 5.  Addressing the intersecting problems of opioid misuse and chronic pain treatment.

Authors:  Richard A Denisco; Redonna K Chandler; Wilson M Compton
Journal:  Exp Clin Psychopharmacol       Date:  2008-10       Impact factor: 3.157

6.  Impact of opioid dose escalation on the development of substance use disorders, accidents, self-inflicted injuries, opioid overdoses and alcohol and non-opioid drug-related overdoses: a retrospective cohort study.

Authors:  Corey J Hayes; Erin E Krebs; Teresa Hudson; Joshua Brown; Chenghui Li; Bradley C Martin
Journal:  Addiction       Date:  2020-01-15       Impact factor: 6.526

7.  Hormone replacement therapy in morphine-induced hypogonadic male chronic pain patients.

Authors:  Anna Maria Aloisi; Ilaria Ceccarelli; Maria Carlucci; Annalisa Suman; Gianfranco Sindaco; Sergio Mameli; Valentina Paci; Laura Ravaioli; Giandomenico Passavanti; Valeria Bachiocco; Gilberto Pari
Journal:  Reprod Biol Endocrinol       Date:  2011-02-18       Impact factor: 5.211

8.  Cancer Pain: A Critical Review of Mechanism-based Classification and Physical Therapy Management in Palliative Care.

Authors:  Senthil P Kumar
Journal:  Indian J Palliat Care       Date:  2011-05

9.  An Investigation into Proteomic Constituents of Cerebrospinal Fluid in Patients with Chronic Peripheral Neuropathic Pain Medicated with Opioids- a Pilot Study.

Authors:  Jonathan Royds; Hilary Cassidy; Melissa J Conroy; Margaret R Dunne; David Matallanas; Joanne Lysaght; Connail McCrory
Journal:  J Neuroimmune Pharmacol       Date:  2020-11-20       Impact factor: 4.147

10.  Going beyond efficacy: strategies for cancer pain management.

Authors:  J Myers; N Shetty
Journal:  Curr Oncol       Date:  2008-01       Impact factor: 3.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.